Filing Details

Accession Number:
0000899243-21-007141
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-18 17:09:13
Reporting Period:
2021-02-16
Accepted Time:
2021-02-18 17:09:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1655759 Arvinas Inc. ARVN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421914 A Sean Cassidy C/O Arvinas, Inc.
5 Science Park, 395 Winchester Ave.
New Haven CT 06511
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-16 6,815 $16.00 161,599 No 4 M Direct
Common Stock Acquisiton 2021-02-16 35,144 $16.00 196,743 No 4 M Direct
Common Stock Disposition 2021-02-16 8,158 $77.60 188,585 No 4 S Direct
Common Stock Disposition 2021-02-16 19,303 $78.61 169,282 No 4 S Direct
Common Stock Disposition 2021-02-16 3,958 $79.32 165,324 No 4 S Direct
Common Stock Disposition 2021-02-16 396 $80.28 164,928 No 4 S Direct
Common Stock Disposition 2021-02-16 2,793 $77.62 162,135 No 4 S Direct
Common Stock Disposition 2021-02-16 6,160 $78.65 155,975 No 4 S Direct
Common Stock Disposition 2021-02-16 1,161 $79.42 154,814 No 4 S Direct
Common Stock Disposition 2021-02-16 30 $80.43 154,784 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-02-16 6,815 $0.00 6,815 $16.00
Common Stock Stock Option (right to buy) Disposition 2021-02-16 35,144 $0.00 35,144 $16.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2028-09-25 No 4 M Direct
46,262 2028-09-25 No 4 M Direct
Footnotes
  1. The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.04 to $78.035, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (10) to this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.04 to $79.03, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.04 to $79.91, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.04 to $80.74, inclusive.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.05 to $78.04, inclusive.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.09 to $79.07, inclusive.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.10 to $79.91, inclusive.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.42 to $80.86, inclusive.
  11. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017 and the remainder of the shares vested in equal monthly installments following January 1, 2017 through January 1, 2020.
  12. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.